富士製薬工業(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4554/E00975-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2025/03/14日証協無担保2,300株0%200株0%1,600株-70.38%
2025/03/14日証協有担保92,460株-52.56%70,382株+83.33%92,392株+58.75%
2025/03/07日証協無担保0株0%0株0%5,402株-57.8%
2025/03/07日証協有担保194,887株-37.88%38,391株+72.93%58,200株-42.79%
2025/02/28日証協無担保0株0%0株0%12,802株+299.06%
2025/02/28日証協有担保313,738株+67.06%22,200株-47.51%101,733株+364.53%
2025/02/21日証協無担保0株-100%0株0%3,208株-53.51%
2025/02/21日証協有担保187,796株-45.82%42,291株-63.44%21,900株-69.92%
2025/02/14日証協無担保500株0%0株0%6,901株-10.52%
2025/02/14日証協有担保346,606株+48.77%115,682株+104.2%72,816株+32.63%
2025/02/07日証協無担保0株-100%0株0%7,712株+305.89%
2025/02/07日証協有担保232,975株+0.98%56,652株-28.59%54,900株-15.41%
2025/01/31日証協無担保100株-80%0株0%1,900株-36.73%
2025/01/31日証協有担保230,716株+76.85%79,329株+223.73%64,900株+93.33%
2025/01/24日証協無担保500株0%0株0%3,003株+1379.31%
2025/01/24日証協有担保130,460株-38.5%24,505株-46.64%33,569株-57.67%
2025/01/17日証協無担保0株0%0株0%203株-96.24%
2025/01/17日証協有担保212,118株-24.49%45,923株-41.93%79,298株-38.32%
2025/01/10日証協無担保0株0%0株0%5,401株+315.46%
2025/01/10日証協有担保280,911株+354.96%79,082株+154.36%128,568株+127.96%
2024/12/30日証協無担保0株-100%0株0%1,300株-71.74%
2024/12/30日証協有担保61,744株-75.41%31,091株-65.6%56,400株+2.36%
2024/12/27日証協無担保700株+75%0株0%4,600株+411.11%
2024/12/27日証協有担保251,077株+2263.97%90,382株+111.02%55,100株+113.83%
2024/12/20日証協無担保400株-98.03%0株0%900株-43.79%
2024/12/20日証協有担保10,621株-75.81%42,830株-37.46%25,768株+731.23%
2024/12/13日証協無担保20,300株+1350%0株0%1,601株+14.36%
2024/12/13日証協有担保43,900株+422.68%68,482株-11.91%3,100株-73.5%
2024/12/06日証協無担保1,400株-90.14%0株0%1,400株-78.79%
2024/12/06日証協有担保8,399株-95.7%77,743株+68.71%11,700株-92.15%
2024/11/29日証協無担保14,200株+140.68%0株0%6,600株+371.43%
2024/11/29日証協有担保195,141株+10.5%46,082株+277.23%148,980株+422.74%
2024/11/22日証協無担保5,900株0%0株0%1,400株-22.27%
2024/11/22日証協有担保176,597株+21.93%12,216株-34.67%28,500株-42.7%
2024/11/15日証協無担保0株-100%0株0%1,801株-68.4%
2024/11/15日証協有担保144,833株-23.31%18,700株-45.32%49,734株+234.91%
2024/11/08日証協無担保24,658株+9999.99%0株0%5,700株+1800%
2024/11/08日証協有担保188,867株+3.26%34,200株+194.83%14,850株-66.77%

※株式分割は考慮していませんのでご注意ください。

Page Top